Australia appears to be experience potentially transformative treatment for obesity: Retatrutide. This dual compound – acting on both GLP-1 and GIP receptors – demonstrates promising results in international research, indicating substantial reductions in weight. While approval hasn't occurred with Australian regulators, several individuals batt